Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease

Lancet. 2000 Aug 19;356(9230):610-2. doi: 10.1016/S0140-6736(00)02598-8.
No abstract available

MeSH terms

  • Anti-Ulcer Agents / adverse effects*
  • Anti-Ulcer Agents / therapeutic use
  • Barrett Esophagus / etiology
  • Barrett Esophagus / prevention & control
  • Drug Administration Schedule
  • Esophageal Neoplasms / etiology
  • Esophageal Neoplasms / prevention & control
  • Esophagitis, Peptic / etiology
  • Esophagitis, Peptic / prevention & control
  • Fundoplication
  • Gastric Mucosa / microbiology
  • Gastric Mucosa / pathology
  • Gastrins / blood
  • Gastritis / etiology
  • Gastritis / microbiology
  • Gastroesophageal Reflux / complications
  • Gastroesophageal Reflux / drug therapy*
  • Gastroesophageal Reflux / surgery
  • Helicobacter Infections / complications
  • Humans
  • Omeprazole / adverse effects*
  • Omeprazole / therapeutic use
  • Proton Pump Inhibitors
  • Time

Substances

  • Anti-Ulcer Agents
  • Gastrins
  • Proton Pump Inhibitors
  • Omeprazole